Investigating risk factors for heart procedures at Beijing Friendship Hospital
Official title: Risk Factor for Percutaneous Coronary Intervention in the Beijing Friendship Hospital
Run by Beijing Friendship Hospital · NCT05728580 · Data updated 2026-11-12
This study is trying to find out what risk factors might affect patients with heart disease who need a specific heart procedure, to help improve their treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 31, 2017 |
| Main results expected | December 31, 2022 |
| Study ends | December 31, 2027 |
| Registry record updated | March 25, 2024 |
| Trial ID | NCT05728580 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are undergoing PCI for coronary heart disease.
✕Probably not a fit
Patients who have experienced failed PCI treatments or are unable to comply with follow-up procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify potential risk factors associated with percutaneous coronary intervention (PCI) in patients with coronary heart disease. By stratifying the risk of these patients, the study seeks to uncover the prognostic value of various risk factors to improve treatment strategies. The primary outcomes measured will include major adverse cardiac and cerebrovascular events (MACCE) and all-cause mortality. The findings could lead to enhanced patient care and reduced healthcare costs.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and management strategies for patients undergoing PCI, ultimately enhancing their quality of life.
How similar studies have gone: Other studies have shown success in identifying risk factors related to PCI, suggesting that this approach is both relevant and valuable.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age greater than or equal to 18 years at the time of admission to the hospital * PCI patients with coronary heart disease: according to the criteria interpreted in the 2011 American Guidelines for Percutaneous Coronary Intervention. The successful diagnostic criteria of PCI: residual stenosis of the treated vessel\<10% (preferably 0%), and the forward flow is TIMI grade 3, there is no dissection that affects the flow, no important side branch occlusion, no visible thrombus and peripheral embolism. Exclusion Criteria: * Patients who failed in PCI treatment; * Current known inability to follow instructions or comply with follow-up procedures.
Where it's running
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Bingbing Ke, Dr
- Email: 1017120710@qq.com
- Phone: 15510286857
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing higher and lower doses of heparin for heart procedures
This study is testing whether using a higher dose of heparin during heart procedures helps patients do better than using a lower dose.
-
Pilates breathing vs diaphragmatic breathing after PCI
This study tests whether Pilates breathing or diaphragmatic breathing helps improve oxygen levels and heart-rate variability in people who just had PCI.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.